| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/04/2008 | US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/04/2008 | US20080213284 Receptor binding polypeptides |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |
| 09/04/2008 | US20080213282 Therapeutic mixture comprising antibody fragment specifc to nerve growth factor for use in treatment of neuropathic pain |
| 09/04/2008 | US20080213280 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor |
| 09/04/2008 | US20080213279 Blocking Leukocyte Emigration and Inflammation By Interfering With Cd99l2 |
| 09/04/2008 | US20080213277 Peptide hormone specific monoclonal antibody for use in diagnosis, prognosis, prevention and treatment of blood, cell proliferative, inflammatory, kidney and liver disorders |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213268 Neuropilin antagonists |
| 09/04/2008 | US20080213267 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 09/04/2008 | US20080213266 Chemokine receptor 4 (CCR4) specific immunoglobulin for use in prevention and treatment of allergic and/or inflammatory diseases |
| 09/04/2008 | US20080213265 Human cytomegalovirus neutralising antibodies and use thereof |
| 09/04/2008 | US20080213263 Methods and compositions for treatment of immune dysfunction disorders |
| 09/04/2008 | US20080213262 Inhibition of Islet Amyloid Polypeptide (Iapp) Aggregation for the Treatment of Type 2 Diabetes |
| 09/04/2008 | US20080213260 Administering an anti-CD23 antibody, an anti-CD20 antibody, and a chemotherapeutic agent; B cell chronic lymphocytic leukemia (B-CLL). |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |
| 09/04/2008 | US20080213256 Less Immunogenic Binding Molecules |
| 09/04/2008 | US20080213254 Immunoglobulin capable of linking immunoreceptor tyrosine-based activation motif (ITAM) with immunoreceptor tyrosine-based inhibition motif (ITIM) for use in treatment of allergic disorders; gene therapy |
| 09/04/2008 | US20080213251 Hexokinase specific immunoglobulin for use in treatment and prevention of asthma, chronic obstructive pulmonary disease, multiple sclerosis, psoriasis, rheumatoid arthritis, osteoarthritis, inflammatory bowel, immune mediated diabetes and pancreatic disorders |
| 09/04/2008 | US20080213249 Conjugation; Fab fragments; for treatment of cancer metastasis |
| 09/04/2008 | US20080213232 Radial Glial Cells Promote Nerve Regeneration and Functional Recovery Following Spinal Cord Injury |
| 09/04/2008 | US20080213224 Using heat shock organizing protein (BABA) specific immunoglobulin as diagnostic tool in detection of campylobacter infection |
| 09/04/2008 | US20080213212 Using sialoadhesin specific immunoglobulin as diagnostic and/or therapeutic tool in treatment and prevention of allergic, respiratory, cell proliferative and skin disorders |
| 09/04/2008 | US20080213171 Cancerous disease modifying antibodies |
| 09/04/2008 | US20080213170 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 09/04/2008 | US20080213169 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 09/04/2008 | US20080213168 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 09/04/2008 | US20080213167 administering an anti-CD23 antibody and chlorambucil; B cell chronic lymphocytic leukemia |
| 09/04/2008 | US20080213166 Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas |
| 09/04/2008 | DE102007009751A1 Diagnostic immunoassay for procalcitonin in a biological sample from a patient comprises selectively determining full-length procalcitonin 1-116 |
| 09/04/2008 | CA2679503A1 Nitrilases, nucleic acids encoding them and methods for making and using them |
| 09/04/2008 | CA2679400A1 Combination therapy for treatment of immune disorders |
| 09/04/2008 | CA2679399A1 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases |
| 09/04/2008 | CA2679381A1 Engineered anti-il-23r antibodies |
| 09/04/2008 | CA2679266A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | CA2678626A1 Anti-ip-10 antibodies and methods of use thereof |
| 09/04/2008 | CA2677771A1 Method for cloning cognate antibodies |
| 09/04/2008 | CA2676049A1 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 09/04/2008 | CA2660592A1 Humanized fc.gamma.riib-specific antibodies and methods of use thereof |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964851A1 Treatment of micro-organism infection |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1963509A1 Catecholamine regulated protein |
| 09/03/2008 | EP1963492A2 Materials and methods for treating chronic fibrotic disease |
| 09/03/2008 | EP1963482A1 Avirulent isolate of neospora caninum and its uses |
| 09/03/2008 | EP1963372A2 Anti-mn antibodies and methods of using same |
| 09/03/2008 | EP1963371A2 Human monoclonal antibodies to o8e |
| 09/03/2008 | EP1963370A1 Bispecific ligands with binding specificity to cell surface targets and methods of use therefor |
| 09/03/2008 | EP1963369A2 Il-21 antagonists |
| 09/03/2008 | EP1963368A1 Anti-il-17 antibodies |
| 09/03/2008 | EP1963367A2 Polishing steps used in multi-step protein purification processes |
| 09/03/2008 | EP1963366A2 Methods for cyclic nucleotide determination |
| 09/03/2008 | EP1962961A1 Demibodies: dimerisation-activated therapeutic agents |
| 09/03/2008 | EP1962907A2 Protein formulations with reduced viscosity and uses thereof |
| 09/03/2008 | EP1962903A1 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or fltl antagonist for treating cancer |
| 09/03/2008 | EP1587532B1 Survivin-derived peptides and use thereof |
| 09/03/2008 | EP1552300A4 Sets of digital antibodies directed against short epitopes, and methods using same |
| 09/03/2008 | EP1476468B1 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 09/03/2008 | EP1430083B1 T1r taste receptors and genes encoding same |
| 09/03/2008 | EP1411118B1 Cell proliferation inhibitors containing anti-glypican-3 antibody |
| 09/03/2008 | EP1351988B1 Group 2 allergen specific igg molecules and use thereof |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1291429B1 Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 09/03/2008 | EP1200121B1 Fish vaccine |
| 09/03/2008 | EP1161455B1 A novel chimeric protein for prevention and treatment of hiv infection |
| 09/03/2008 | EP0934339B1 Detoxification by intramuscular administration of F(ab') 2 fragments |
| 09/03/2008 | EP0906577B1 Screening compounds for the ability to alter the production of amyloid-beta peptide |
| 09/03/2008 | EP0789575B1 Peripheral nervous system specific sodium channels, dna encoding therefor, drug screening, and methods of making and using thereof |
| 09/03/2008 | EP0710116B1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 09/03/2008 | CN101258241A Nucleic acid capable of binding to immunoglobulin G and use thereof |
| 09/03/2008 | CN101258240A Protein preparation containing S1-5 |
| 09/03/2008 | CN101258166A Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 09/03/2008 | CN101258165A Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
| 09/03/2008 | CN101258164A A method for the mass production of immunoglobulin fc region deleted initial methionine residues |
| 09/03/2008 | CN101257917A Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
| 09/03/2008 | CN101255425A OX2 receptor homolog |
| 09/03/2008 | CN101255196A Immune globulin single variant antigen bonding land and specificity construction body thereof |
| 09/03/2008 | CN101255195A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 09/03/2008 | CN101255194A Rabbit anti-human MK monoclonal antibody as well as hybridoma cell strain and uses thereof |
| 09/03/2008 | CN101255193A Preparation of specific antibodies aiming at PCDH10C terminal protein segment molecule |
| 09/03/2008 | CN101255192A Soluble CTLA4 mutant molecules and uses thereof |
| 09/03/2008 | CN101254304A Medicaments for treating micro-organism infection and use thereof |
| 09/03/2008 | CN101254303A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 09/03/2008 | CN100415871C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 09/03/2008 | CN100415772C Anti-ErbB2 antibodies |
| 09/03/2008 | CN100415765C Methods for humanizing rabbit monoclonal antibodies |
| 09/02/2008 | US7420047 Nucleotide sequence encoding antigenic peptide; induces immune response which does not cause anaphylaxis when administered; safety |
| 09/02/2008 | US7420045 IAPs associated cell cycle proteins, compositions and methods of use |
| 09/02/2008 | US7420043 Reagents for detecting efavirenz |
| 09/02/2008 | US7420042 Soluble neuropilin/growth factor receptor fusion proteins |
| 09/02/2008 | US7420041 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 09/02/2008 | US7420040 Cell surface glycoprotein specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; antitumor agents |
| 09/02/2008 | US7420039 Conjugated with toxins, enzymes, radioactive compounds, and hematogenous cells; use in staging and diagnosis; treatment of metastasis |
| 09/02/2008 | US7420030 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 09/02/2008 | US7420028 Replikins and methods of identifying replikin-containing sequences |
| 09/02/2008 | US7419825 Propagation of neural stem cells; obtain cells, detect expression of neuronal cell markers, recover cells expressing neuronal marker, propagate cells |
| 09/02/2008 | US7419824 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 09/02/2008 | US7419811 Mutant kinase; anticancer agents; supplying to leukemia blastocytes; antibody which detects cell surface antigen; antiproliferative agent |
| 09/02/2008 | US7419807 High molecular weight; isolated nucleic acid; use in detecting antibodies in test sample; diagnostic kit |